1/213
i'm not a normal uncle i'm a furuncle
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
normal/ common skin flora
coagulase negative staph
corynebacterium
cutibacteria
viridans streptococci
bacillus
normal/ common GI tract flora
firmicules (strep/staph)
bacteriodetes (bacteriodies)
proteobacteria (ham, esch, kleb, citro)
actinobacteria (coryn, actino)
normal typical flora- anaerobes
majority Bacteroidetes class
otherwise diverse
typical oral microbiome
streptococci
anaerobes→ hide in oral biofilm
blood cultures- what to assume is infection until otherwise known
staph aureus
strep. pyogenes (GA)
strep. alalactiae (GB)
strep. pneumoniae
enterobacterales
pseudomonas aeruginosa
bacteriodies fragilis
candida
blood culture: typical contaminents
coag negative staph→ especially staph epi
bacillus (non anthrax)
corynebacterium
viridians strep
cutibacterium
clostridium perfengens
micrococcus
if blood cultures positive- what should you evaluate?
any sx?
any IV devices?
IV thrombus?
immunocompromised?
how many cultures were taken, and from what sites?
what is the most important practice in disease control
hand hygiene
steps to put PPE on
gown
mask
goggles/faceshield
gloves
how to take PPE off
gloves
gown
goggles/faceshield
mask
hand hygiene
skin and soft tissue classifications of disease
necrotizing (deeper) vs non necrotizing
purulent(abscess or fluid collection) vs non purulent
complicated vs non complicated
deep infections (dermis/subcutaneous)
rapidly progressing
surgical intervention
@ higher risk for complicated pt populations
community associated MRSA- outpt treatment options
TMP-SMX
clindamycin (D-test)
oxazolidinones (linezolid)
tetracyclines(doxy,mino)
delafloxacin
MRSA- inpt treatment
gram +/MRSA only
vancomycin
linezolid
daptomycin
other lipoglycopeptides
if mixed or other failed
5th gen cephalosporins: ceftaroline, ceftobiprole
tetracycline
non bullus impetigo sx
white/ purulent discharge in vessel
when bursts leaves a yellow/ brown crust on the skin
bullous impetigo sx
yellow/ clear fluid in vessel
red base when burst
impetigo treatment
mild cases:
topical mupirocin or ozenoxacin($$)
more severe:
oral dicloxacillin or cephalexin (MSSA)
oral TMP-SMX, doxycycline OR clindamycin (MRSA, allergy or fail other)
duration: 5-7 days
impetigo treatment duration
5-7 days
folliculitis
limited to epidermis(hair follicules)
multiple small lesions
typically are self limiting- resolve on their own→ otherwise non drug treatments:
warm compress
furuncles
infection of hair follicles, purulent material extends into dermis and subcutaneous tissue→ worsens to carbuncle
carbuncle
group of inflamed follicles in single mass with drainage from multiple follicles
furuncles and carbuncles treatment
moist heat compress→ if smaller
larger:
incision and drainage→ take culture
oral abx:
empiric coverage abx- TMP/SMX, doxycycline, clindamycin
cellulitis presentation
redness, swelling, warmth and pain + systemic infection
when to hospitalize for cellulitis
fever
rigors
metal status change
shock
dramatic skin infection(large fluid collections)
cellulitis inpt treatment
erysipelas (clear demarkation)
IV cefazolin
non-purulent
IV cefazolin: mod/severe @ 50% risk
vanco/linezolid: more severe/ high risk +broad spectrum in addition to MRSA coverage (immunocompromised, necro/deep shock, abx failure)
purulent:
vanco or linezolid
cellulitis outpatient treatment
erysipelas (streptococcus)
PCN or amoxicillin
non-purulent (often strep):
dicloxacillin or cephalexin
purulent (MRSA coverage ± strep)
SMX/TMP, doxycycline, clindamycin
duration: 5-14 days
cellulitis outpt treatment duration
5-14 days
what to do for bites?
irrigate with soap or povidine-iodine
check immunization record
when is abx prophylaxis indicated for bites?
immunocompromised
asplenia
wounds to hands, face or genitals
deep puncture wounds or close proximity to bones/joints
advance liver disease
abx for bite prophylaxis
amoxicillin- clavualante preferred
alternatives:
doxycycline, TMP/SMX, cefuroxime
OR fluoroquiolones + metronizadole/ clindamycin
use PO for less severe
IV for more severe cases:
amp-sulbactam, ceftriaxone+metronizadole or pip-tazo
cefoxitin
ertapenem
fluoroquinolone w/ metronizadole or clindamycin
ALSO consider post exposure rabies or tetanus
UTI risk factors
increased age
female sex
pregnancy
obstruction
DM
prostatic hypertrophy
anticholinergic drugs
neurological disease
catheterization or instrument
sexually active
uncomplicated UTI (cystitis) symptoms
dysuria- painful
urgency
frequency
gross hematuria (blood)
nocturia
suprapubic heaviness
complicated UTI (pyelonephritis) symptoms
fever
N/V
malaise
flank pain
CVA tenderness
therapy for UNCOMPLICATED cystitis
nitrofurantoin→ narrow specturum (ecoli, S.saproph)
100mg BID x 5d
avoid: CrCl<30, pyelonephritis
ADE: mimic CHF or pneumonia
fosfomycin→ covers VRE, ESBL, KPC, pseudomonas
3g, 1 dose ONLY ($$)
avoid: pyelonephritis
ADE: GI SE common
SMX/TMP→ covers typical uropathogens, resistance increasing(do not use for empiric coverage)
avoid: sulfa allergies
2nd line- due to increased resistance
cipro, levo, delafloxacin
so many ADE
beta lactams: pediatric pts, recurrent UTI more common with BL
urethritis
most likely an STD
when negative urine culture w/ +WBC in urinalysis + lack of response to abx treatment
urethritis treatment
azithromycin 1gm x 1 dose OR
doxycycline 100mg BID x 7d
definition of recurrent UTI
>2 UTI within 6 months
risk factors for recurrent UTI
correctable UT abnormality
sexual practices or use of spermicides or diaphragms
NO evidence for: post coital voiding, hygiene, douching, tight underwear or hot tubs
treatment for prophylaxis of UTI: post coital
TMP-SMX 40/200
TMP-SMX 80/400
nitrofurantoin 50-100mg
cephalexin 250mg
treatment for prevention of UTI: chronic
TMP 100mg 1x/d
TMP-SMX 40/200 1x/d
TMP-SMX 40/200 3x/week
nitrofurantoin 50-100mg daily
cephalexin 125-250mg daily
fosfomycin 3g q10days
other non drug prophylaxis for recurrent UTI
hydration(make sure not too much, >1.5L)
cranberry (not helpful during active infection, make sure is actual active form of cranberry)
other drug prophylaxis for recurrent UTI
vaginal estrogen in perimeno and postmenopausal women
methenamine hippurate→ LAST RESORT
in the urine is changed to formaldehyde
don’t use with vitamin C→ specific pH is needed to change into formaldehyde
complicated UTI
is beyond the bladder, typically kidney type infection
treatment will differ based on if the patient is septic or not
treatment of complicated UTI with sepsis- with or without shock
3rd GCephalosporin or 4th GC
carbapenems
pip-tazo
fluoroquiolones
treatment of complicated UTI without sepsis- IV route
3rd GCephalosporin or 4th GC
pip-tazo
fluoroquiolones
treatment of complicated UTI without sepsis- PO
fluoroquinolones
SMX-TMP
what IV abx for complicated UTI cover pseudomonas
cefepime: 1-2g every 8-12 hours
ceftazidime: 1-2g every 8 hours
pip-tazo: 4.5g every 8 hours
most common empiric abx for complicated uti
ceftriaxone: 1-2g daily
can you use another drug as a surrogate marker for susceptibilty
NO- sometimes you can make inferences but specifically for the exam pick one of the drugs that it says it is susceptible to!
duration of therapy for complicated UTI
fluoroquinolones:
5-7d
non-fluoroquinolones:
7d
what abx can you use for complicated UTI caused by CTX-M(ESBL) bug
fosfomycin IV
SMX-TMP IV or PO (if S)
cipro/levofloxacin IV or PO (if S)
meropenem, imipenem, ertapenem IV (if S)
this is likely what you would start with
what abx can you use for complicated UTI caused by MECA/MECC(MRSA) bug
vancomycin IV
daptomycin IV
linezolid IV or PO
what is true about catheter associated UTIs
common to see more resistance
important to remove as soon as possible to decrease risk
carbapenem resistant enterobacteriacae (CRE)
difficult as it knocks out most:
PCN
cephalosporins
carbapenems
prostatitis
inflammation of prostate gland from infection→ due to reflux of infected urine back into the gland
prostatitis acute sx
chills
fever
dysuria
irritation
increased uriniary frequency
localized rectal pain
urinary training
prostatitis chronic sx
difficulty urinating
epididymitis
lower back pain
recurrent UTIs
urethritis
acute prostatitis treatment duration
@ least 2-4w
chronic prostatitis treatment duration
@ least 6-12 w
outpatient prostatitis treatment options
ciprofloxacin 500mg BID 10-14d
levofloxacin 500-750mg daily 10-14d
SMP-TMP (if S)
inpatient prostatitis treatment
cipro or levo IV
pip-tazo + aminoglycoside
cefotaxime
ceftazidime
prostatitis treatment monitoring
improvement should be within 48-72hrs
follow up urine culture results
optimization of therapy and monitor drug therapy as needed
UTI in pregnancy
ALWAYS treat→ even if no symptoms for a total of 7d
lower UTI: nitro or cephalosporin
upper: IV ampicillin+gentamycin or Extended Spectrum BetaLactam
UTI in pediatrics
treatment total for 7 days
avoid fluoroquinolones and tetracyclines
TMP-SMX treatment monitoring
SCr→ CrCL<30
K→ prolonged use= increased K
nitrofurantoin monitoring
SCr→ CrCL<30
liver (periodic for cholestasis)
fluoroquinolone monitoring
SCr→ CrCl<50
liver→ acute or chronic injury
QTc→ >500 can increase risk of TdP
blood glucose (hypo/hypers)
beta-lactams monitoring
SCr→ check CrCl, differs from drug to drug
anaphylaxis
pros and cons of nitrofurantoin for UTI
pros:
low resistance rates
low costs
cons:
longer treatment duration→ 5d
not useful for pyelonephritis
renal issues→ efficacy and toxicity
pros and cons of fosfomycin for UTI
pros:
single dose
broad spectrum
low resistance rates
cons
high cost
low availability
not useful for pyelonephritis
pros and cons of SMX-TMP for UTI
pros:
good efficacy for cystitis and pyelonephritis
low cost
cons:
higher resistance rates
sulfa allergy
avoid in 1st trimester of pregnancy
pros and cons of fluoroquinolones for UTI
pros:
good efficacy for cystitis and pyelonephritis
likely susceptible if first UTI
shorter treatment duration(3d)
cons:
collateral damage
lots of potential ADE
avoid in pregnancy, children
pros and cons of BL for UTI
pros:
lower rates of resistance
relatively low costs
cons:
more treatment failures than others
longer treatment duration(5-7d)
frequent dosing
PCN allergies common
asymptomatic bacteriuria treatment indicated for:
immunocompromised individuals
pregnant patients- screen @ 1st visit
prior to invasive urological procedure
NOT indicated for:
healthy women
older adults
people with diabetes, indwelling catheters or spinal cord injuries
nitrofurantoin ADE
avoid CrCl<30
avoid in pyelonephritis
can mimic CHF, pneumonia
TMP-SMX ADE
not recommended for empiric therapy→ due to increased resistance
avoid if ‘sulfa’ allergy
avoid if 1st trimester of pregnancy
fosfomycin ADE
avoid in pyelonephritis (PO)
Gi SE are common
fluoroquinolones ADE
tendonitis/tendon rupture→ any tendon, up to 6mo-1yr after
risk if increased with corticosteroid use
50% within 14d of use
levofloxacin- most
ciprofloxacin
moxifloxacin -least
peripheral neuropathy(sensory and motor)→ can be from a short course
CNS: can cause seizures(removes inhibition), acute encephalopathy
CDI: strong association due to collateral damage
glucose regulation
phototoxicity
aortic aneurysm/dissection→ high mortality, 1/1376 collagen turnover
psychiatric rxn→ some mania or acite anxiety
insomnia with levofloxacin
delirium with cipro and moxi
QTc prolongation: cardiotoxicity, increased risk of TdP
avoid in pregnancy and children
gram negative intrinsic resistance mechanisms
abx must make it through porins and evade efflux transporters and BLases to get into the site
these do not change as much
gram positive intrinsic resistance mechanisms
receptors change more frequently
help increase resistance to abx
plus need to avoid BLases to not be inactivated
beta lactamases
all have serine at the active site
Class A
Class C
Class D
class A beta-lactamases
ESBL→ SHV, TEM, CTM-X(most common), KPC
these hydrolyze 3rd GC
class C ‘cephalosporinases’
AmpC, CMY, FOX, MOX
class D beta lactamases
OXA (oxacillin hydrolyses)
some can also hydrolyze carbapenems
metallo- Blactamases: class B
Zn at the active site
IMP, VIM, NDM-1
ecoli beta-lactamases
WT:
TEM-1= resistance to PCN, amox and amp
due to hyperproduction= R to 1st gen cephalosporins (cefazolin)
ADD a BLI to overcome this
mutation:
ESBL 3rd GC hydrolysis
R to cefepime and pip-tazo
typically still S to carbapenems
klebsiella pneumonia beta lactamases
WT:
SHV-1→ resistance to PCN, amox, and amp
usually still S to cephalosporins
ADD BLI to increase susceptibility- especially with pipercillin
mutation:
SHV-1= ESBL hydrolyze 3rd GC
R to cefepime and pip-tazo
still S to carpenems
class C: ampC- HECK YES
Enterobacter cloacae
citrobacter freundii
klebsiella aeruogenes
assume all are R to 3rd GC (except for cefepime)
class D: OXA- acinetobacter
some can hydrolyze carbapenems→ this would typically be the DOC for this bug
overcomes BL stability (bulky R1 group to block hydrolysis)
pseudomonas aeruginosa- MDR (relatively rare→ all come together)
OM→ <10% of porin proteins found in typical E.coli
slow process to cross outer membrane
oprD- imipenem and meropenem
chromosomal BL- ampC(PDC) pseudo derived
inducible→ slow hydrolysis/ interaction coupled with slow entry
efflux: MexAB-oprM
resistance from PBP in gram negative
PBP is super conserved here→ uncommon for resistance due to mutations to arise here
carbapenem resistance in Proteus, Providenci and Morganella
resistance in gram + is due to
alternate PBP acquired from an amino acid change
what BLases are inhibited by BLI
class A
class C
class D
they can also inhibit some metallo b-lactamases→ class B
molecular resistance detection
not 100% detection
specific resistance for specific bugs
MRD for enteroccus faecalis/faecium
VanA (VRE)
MRD for staph aureus
MecA/C
MRD for enterobacterales (Ecoli, K.pneumoniae)
CTX-M(ESBL)
or carbapenemases: KPC, IMP, NDM, OXA, VIM
concentration independent killing
see MAX kill rate—> @ a certain point does not do better to increase the concentration
concentration dependent killing
PEAK dependent
rate and extent of the killing increases when the concentration is greater than MIC
examples of this are aminoglycosides, fluoroquinolones
time dependent killing
continuous infusion
limited increase in the rate and extent of killing w a concentration greater than MIC
BL are MAX killing at 4x MIC
what fluoroquinolone can you not use for CAP
ciprofloxacin